submits

  1. T

    Takeda Submits New Drug Application In The U.S. For Investigational Type 2 Diabetes T

    Takeda Pharmaceutical Company Limited (Takeda) announced that its wholly-owned subsidiary Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for the fixed-dose combination therapy...
    • tD33NAt
    • Thread
    • application diabetes drug investigational submits takeda type
    • Replies: 0
    • Forum: Health and Fitness
  2. T

    Eisai Submits Marketing Authorization Application In Japan For Insomnia Treatment Se

    Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced that it has submitted a Marketing Authorization Application (MAA) to the Japanese Ministry of Health, Labour and Welfare seeking approval for SEP-190 (generic name: eszopiclone), a product the company has been...
    • tD33NAt
    • Thread
    • application authorization eisai insomnia japan marketing submits treatment
    • Replies: 0
    • Forum: Health and Fitness
  3. T

    Ethicon Submits Biologic License Application To The FDA For The Fibrin Pad

    Ethicon, Inc., a worldwide leader in surgical care, announced that the company has submitted a Biologic License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the Fibrin Pad, a novel product candidate that combines Ethicon's biomaterials and plasma-derived biologics (Human...
    • tD33NAt
    • Thread
    • application biologic ethicon fda fibrin license pad submits
    • Replies: 0
    • Forum: Health and Fitness
  4. T

    Nanotherapeutics Submits Investigational New Drug Application To FDA For Clinical Tes

    Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine...
    • tD33NAt
    • Thread
    • application clinical drug fda investigational nanotherapeutics submits tes
    • Replies: 0
    • Forum: Health and Fitness
  5. T

    Biodel Submits VIAject(R) New Drug Application To FDA For Treatment Of Diabetes

    Biodel, Inc. (Nasdaq: BIOD) announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for clearance to market VIAject® as a treatment for diabetes. VIAject® is Biodel's proprietary formulation of recombinant human insulin that is designed to be...
    • tD33NAt
    • Thread
    • application biodel diabetes drug fda submits treatment viajectr
    • Replies: 0
    • Forum: Health and Fitness
Top